medigraphic.com
ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México

2025, Number 1

<< Back Next >>

Arch Med Urg Mex 2025; 17 (1)

Leukocyte glucose index as a prognostic marker for peritonitis associated with peritoneal dialysis

Ávila-Salcedo DR, Ayala-San Pedro JA, Lozano-Nuevo JJ, Mendoza-Portillo E, Montes-Hernández PA, Mesta-Carrillo LF

Language: Spanish
References: 14
Page: 10-14
PDF size: 176.79 Kb.


ABSTRACT

Introduction: dialysis-associated peritonitis (DAP) is a common and serious complication. The leukocyte‑glucose index (LGI) has proven useful as a prognostic marker in various pathologies and could be a valuable tool for predicting DAP, thereby improving clinical decision‑making.
Objective: to establish the association between LGI and the development of DAP..
Materials and methods: acase–control study was conducted in 49 patients at Ministry of Health hospitals in Mexico City who presented with dialysis urgency and underwent placement of their first dialysis catheter. LGI was measured on admission, and its association with subsequent development of DAP was evaluated. Proportions were analyzed using Fisher’s exact test, median LGI and hospital length of stay (LOS) with the Mann–Whitney U test, and means with Student’s t-test.
Results: a positive LGI was more frequent in the group that developed DAP (33.5% vs. 4%, p = 0.019), with an odds ratio of 7.08 (95% CI: 1.4–34.3). The median LGI in cases was 1.15 compared to 0.73 in controls (p ‹ 0.05). Differences were also observed in LOS and catheter replacement rates.
Conclusions: LGI is significantly associated with the development of DAP and may serve as a useful prognostic marker for predicting clinical outcomes in these patients.


REFERENCES

  1. Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease.Lancet. 2021;398(10302):786-802. doi:10.1016/S0140-6736(21)00519-5.

  2. Instituto Nacional de Estadística y Geografía. Característicasde las defunciones registradas en México durante 2020. INEGI.Published 2020. Accessed July 30, 2024. https://www.inegi.org.mx/contenidos/programas/mortalidad/doc/defunciones_registradas_2020_nota_tecnica.pdf.

  3. Méndez-Durán A, Méndez-Bueno JF, Tapia-Yáñez T, et al. Epidemiologíade la insuficiencia renal crónica en México. Diálisis y Trasplante.2010;31(1):7-11. doi:10.1016/s1886-2845(10)70004-7.

  4. Aco-Luna JA, Solano-Ramírez A, Saldaña-Guerrero MP, etal. Incidencia de peritonitis asociada a diálisis peritoneal enadultos en un hospital, Puebla, México. Revista CientíficaCiencia Médica. 2019;22(1):24-28. Accessed July 30, 2024.http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332019000100004&lng=es&tlng=es.

  5. Russi Hernández M, et al. Etiología de peritonitis asociada a diálisisperitoneal continua. Archivos de Medicina de Urgencia de México.2013;5(1):5-10.

  6. Cullis B, Al-Hwiesh A, Kilonzo K, et al. ISPD guidelinesfor peritoneal dialysis in acute kidney injury: 2020 update(adults). Peritoneal Dialysis International. 2021;41(1):15-31.doi:10.1177/0896860820970834.

  7. Liu X, Qin A, Zhou H, et al. Novel predictors and risk score oftreatment failure in peritoneal dialysis-related peritonitis. Frontiersin Medicine. 2021;8:639744. doi:10.3389/fmed.2021.639744.

  8. Reyes-Villarreal JC, Morales-Gutiérrez JE, López-ZamoraB, et al. Índice leuco-glucémico en pacientes con infarto miocárdicocon elevación del ST. Rev Med Inst Mex Seguro Soc.2022;60(2):142-148.

  9. Sánchez Avilés TA, Soto-García Ó, León-Miranda AE, et al. Asociaciónentre índice neutrófilo-linfocito y peritonitis relacionadacon diálisis peritoneal. Medicina Interna de México. 2022;38(2).doi:10.24245/mim.v38i2.4814.

  10. Rodríguez-Jiménez A, Fardales-Rodríguez R, Toledo-RodríguezE, et al. Índice leuco-glucémico como factor pronóstico tras un infartoagudo del miocardio con elevación del segmento ST. RevistaFinlay. 2019;9(2). Accessed July 31, 2024. https://revfinlay.sld.cu/index.php/finlay/article/view/636.

  11. Ramos-Hernández WM, Soto L, Del Rosario-Trinidad M, et al.Leukocyte glucose index as a novel biomarker for COVID-19 severity.Scientific Reports. 2022;12(1). doi:10.1038/s41598-022-18786-5.

  12. Seoane LA, Burgos L, Espinoza JC, et al. Prognostic value of theleuko-glycaemic index in the postoperative period of coronary arterybypass grafting. Brazilian Journal of Cardiovascular Surgery.2021;36(4):484-491. doi:10.21470/1678-9741-2020-0349.

  13. Vélez JL, Vélez P, Bucheli R, et al. Evaluación del índice leuco-glicémico como predictor de mortalidad en pacientes sépticosclínico-quirúrgicos y críticos. Rev Med Vozandes. 2016;27:35-40.

  14. Hernández-Sánchez MM, Lozano-Nuevo JJ, Suárez-Cuenca JA,et al. Índice leuco-glucémico asociado con complicaciones enisquemia cerebral aterotrombótica. Medicina Interna de México.2019;35(1). doi:10.24245/mim.v35i1.2180.




2020     |     www.medigraphic.com